Cancer Institute A national cancer institute
designated cancer center

Daniel Chang

Publication Details

  • Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer.

    Schellenberg D, Kim J, Christman-Skieller C, Chun CL, Columbo LA, Ford JM, Fisher GA, Kunz PL, Van Dam J, Quon A, Desser TS, Norton J, Hsu A, Maxim PG, Xing L, Goodman KA, Chang DT, Koong AC. Int J Radiat Oncol Biol Phys. 2011; 81 (1): 181-8

    This Phase II trial evaluated the toxicity, local control, and overall survival in patients treated with sequential gemcitabine and linear accelerator-based single-fraction stereotactic body radiotherapy (SBRT).

    PubMedID: 21549517

Stanford Medicine Resources:

Footer Links: